Open AccessPharmacovigilance
Author(s) -
Adiba Nousheen,
Asra Asra,
Hasnat Fatima,
Nashra Nizami,
Sarah Noureen,
Syed Amair Ali,
B. Tazneem Tazneem,
Syeda Zuleqaunnisa Begum
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v70i01.006
Subject(s) - pharmacovigilance , medicine , quality (philosophy) , engineering ethics , pharmacology , engineering , drug , epistemology , philosophy
Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in theprofessional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs,improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the presentday, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentiallyletters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultrastructured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve suchimportant results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in futureyears.